Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology.
The purpose of the present review is to assess the evidence published in scientific literature that industrial organic solvents as a generic group have the ability to induce long-term nervous system damage in workers that can be detected by techniques other than neuropsychological testing. The main body of evidence considered in this review was 40 studies involving the use of brain imaging, neurophysiological testing, gross autopsy or histopathology in groups of workers with long-term solvent exposure. Case reports involving both solvent abuse and occupational exposure, and experimental animal data have also been reviewed as supporting data. A number of the studies in groups of workers provide evidence of the presence of marginal atrophic abnormalities in the brain or deficits in nerve conduction velocity in solvent-exposed workers. However, there are limitations in the design of many of these studies, the strength of association between exposure and effect is not consistently strong, no dose-response relationship can be detected, the reported changes lack specificity and there is no coherence between the human and experimental animal data. Overall, it is not possible to draw reliable conclusions with respect to the presence or absence of nervous system damage related to the common properties of organic solvents.
Ridgway
P
P
Health and Safety Executive, Health Directorate, Magdalen House, Stanley Precinct, Bootle, Merseyside L20 3QZ, UK. peter.ridgway@hse.gsi.gov.uk
Nixon
T E
TE
Leach
J-P
JP
D000818:Animals; D001921:Brain / Q000473:pathology*; D002908:Chronic Disease; D006801:Humans; D009431:Neural Conduction / Q000187:drug effects* / Q000502:physiology; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D016273:Occupational Exposure / Q000009:adverse effects*; D009930:Organic Chemicals / Q000009:adverse effects*; D012997:Solvents / Q000009:adverse effects*; D014055:Tomography, Emission-Computed
D009930:Organic Chemicals; D012997:Solvents